Key facts
- It has raised $30K; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include ventureLAB Innovation Centre, Front Row Ventures, McMaster University, Ontario Bioscience Innovation Organization.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Arche Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Arche Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arche Biotechnologies
Developer of a smart platform designed to connect hospitals to new medical technology through automated fluid monitoring. The company offers an integrated platform with automated fluid monitoring devices and real-time data visibility, enabling hospitals and clinical teams monitor fluid balance accurately and support timely care decisions.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2024
- Website
- archebiotech.ca/
- Ownership
- Privately Held (backing)
Arche Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arche Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arche Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.